Lilly settles Zyprexa suit
While Zyprexa -- which is still on the market -- is approved to treat schizophrenia and bipolar mania, many of the plaintiffs, Burton [Mark Burton, a partner at the firm of Hersh and Hersh] said, had been prescribed the drug for "off-label" uses, including treatment for depression, anxiety and dementia.
"We always contended that the company did a lot of off-label promotion," he said.
Eli Lilly denies any wrongdoing and said the settlement was just to put a quick end to the cases.
[from The Recorder,
http://www.law.com/jsp/article.jsp?id=1118394317672]
1 Comments:
Zyprexa zenith to zonked
On November 28, 2001, the Journal of the American Medical Association published a letter written by Dr. Elizabeth Koller, an FDA medical officer, Dr. P. Murali Doraiswamy, a Duke University psychiatrist warning that according to FDA's MedWatch data, patients taking olanzapine (Zyprexa) were 10 times more likely to become diabetic than the general population. [JAMA Vol. 286 No. 20.]
The black box warning was put up too late mates!
At a glance,zyprexa was promoted 'off label' to uses that weren't FDA approved.This opens up a can of worms for patients like myself who took it for PTSD for which it was ineffective and moreover gave me diabetes.
It was Eli Lilly that manufactured,promoted and exaggerated the efficacy of it's defective zyprexa product.
Blaming my doctors or myself is like blaming the Supermarket vedor for a tainted brand name food product produced by a longtime trusted supplier.
If i bought a can of General Mills Green Giant string beans that had botulism I would blame the Jolly Green Giant wouldn't you?
True,leaked documents don't convey the 'whole picture' but what is compelling is that zyprexa is the 7th some say 5th largest drug sell in the world and Eli Lilly's #1 drug sale by their own admission.
This is for a drug that won't get you "high" cost $2.50 a pill and only indicated for less than 1% of the population.
Hello! Somebody in Lilly land is pushing zyprexa hard-Daniel Haszard
Post a Comment
<< Home